January 2026 in “Forum Dermatologicum” This study reviewed cases of Graham–Little-Piccardi–Lassueur syndrome and found that topical treatments were generally ineffective, while systemic therapies like prednisone, hydroxychloroquine, and isotretinoin led to partial hair regrowth and disease stabilization, highlighting the importance of early diagnosis and systemic therapy to improve outcomes.
September 2025 in “International Journal of Innovative Technologies in Social Science” This study found that low-dose oral minoxidil (≤5 mg/day) effectively increased hair number and diameter in men and women with androgenetic alopecia, and was generally well-tolerated with mostly mild adverse effects, although serious complications were rare and associated mainly with pre-existing heart conditions.
January 2025 in “Advances in Dermatology and Allergology” This review highlights a gap between patient-reported and physician-perceived rates of alopecia in transplant recipients, suggesting the issue may be underestimated and stressing the need for better recognition and management of hair disorders caused by immunosuppressive therapy post-kidney transplantation.
October 2024 in “Journal of Education Health and Sport” This article reviews treatment options for Alopecia Areata, concluding that topical corticosteroids are effective for mild cases, while systemic therapies are advised for moderate to severe cases.
December 2023 in “Ophtha Therapy” In this study, the aim was to define the indications, diagnostics, and surgical techniques for eyebrow lift procedures, noting that the primary complication is a visible scar, especially concerning for individuals with a tendency for keloid formation.
July 2023 in “Journal of Education, Health and Sport” This literature review reports that micro-needle radiofrequency is increasingly recognized in aesthetic medicine as a safe, effective treatment for various skin conditions, but further research is needed to optimize treatment parameters for the best outcomes.
December 2020 in “Forum Dermatologicum” In this case report, a combination treatment of intralesional triamcinolone acetonide, oral acitretin, and topical clobetasol propionate showed effectiveness in reducing symptoms of Graham-Little-Piccardi-Lasseur syndrome in one patient over two months, with no new areas of hair loss observed.
January 2015 in “Przegla̧d dermatologiczny” This study observed that excimer light therapy, intralesional triamcinolone, and topical 5% minoxidil all had differing levels of effectiveness in treating alopecia areata, with variable results noted among treatments.
9 citations
,
January 2014 in “Postepy Dermatologii I Alergologii” This study evaluated the Polish version of Skindex-29, demonstrating its reliability and validity as a tool to measure quality of life in dermatology patients.
8 citations
,
October 2023 in “Folia Histochemica et Cytobiologica” This study observed that exosomes from adipose mesenchymal stem cells overexpressing hepatocyte growth factor significantly improved liver function and reduced fibrosis in mice with experimentally induced liver injury.
2 citations
,
January 2024 in “Advances in Dermatology and Allergology” This study suggests a potential role for S100A7 and IL-17 in the pathogenesis of lichen planopilaris.
1 citations
,
September 2024 in “Quality in Sport” This review explores the complex biological process of hair graying, highlighting oxidative stress, genetic factors, and interventions like antioxidants and genetic therapy as key aspects affecting the preservation of hair pigmentation.
1 citations
,
July 2024 in “Quality in Sport” This review discusses the impact of lifestyle interventions on managing polycystic ovary syndrome and concludes that such modifications can significantly improve clinical outcomes and the health profile of patients, but reports no new results.
1 citations
,
January 2021 in “Dermatology Review” This case report describes a young man with bilateral morphea en coup de sabre, which recurred after being quiescent, highlighting its association with previous head trauma and alopecia.
April 2026 in “Nowotwory Journal of Oncology” This review provides a clinical guide for safely using dermo-aesthetic treatments to improve the quality of life for oncology patients dealing with treatment-related side effects, emphasizing the importance of consulting with an oncologist before undergoing such procedures.
June 2025 in “Journal of Education Health and Sport” This review highlights that while finasteride and minoxidil effectively treat androgenetic alopecia, emerging options like dutasteride, mesotherapy, androgen blockers, and red LED therapy show promising results, especially when used in combination, though further research is needed for standardization and safety confirmation.
January 2017 in “Postepy Dermatologii I Alergologii” This study investigates the potential role of the corticotropin-releasing hormone system in the pathogenesis of lichen planus but does not report new clinical results, emphasizing the need for further exploration.
January 2026 in “Journal of Education Health and Sport” This review assesses whether using letrozole alongside physical activity and nutrition is clinically beneficial for enhancing ovulation outcomes in women with PCOS-related infertility, but it doesn't report specific results from the evaluation.
January 2026 in “Advances in Dermatology and Allergology” In this study, patients with lichen planopilaris and frontal fibrosing alopecia reported a substantial impairment in quality of life and experienced high levels of stress, often considering stress a cause of their condition.
December 2025 in “International Journal of Innovative Technologies in Social Science” This study found that ritlecitinib, approved for alopecia areata in patients aged 12 and older, has an acceptable safety profile with mild to moderate side effects and no increase in serious adverse events compared to placebo.
January 2024 in “Annals of Agricultural and Environmental Medicine” This study observed that LED therapy improved hair regrowth and reduced hair loss in patients with post-COVID telogen effluvium, with or without androgenetic alopecia, compared to those who did not receive LED treatment.
January 2017 in “mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich)” In this study, women with PCOS who had children reported shorter menstrual cycles and more regular daily routines compared to childless women, who experienced less hirsutism and weight gain.
1 citations
,
January 2017 in “Endokrynologia Pediatryczna” This review concludes that polycystic ovary syndrome can significantly impact aspects of health-related quality of life in adolescent girls, especially body image and interpersonal functioning.
January 2025 in “Advances in Dermatology and Allergology” This study found that the Polish version of the AA-QLI questionnaire is a reliable and internally consistent tool for assessing health-related quality of life in Polish-speaking patients with alopecia areata.
March 2025 in “Forum Dermatologicum” This review explores links between metabolic syndrome and skin diseases, reporting shared mechanisms like inflammation and hormonal imbalances that may influence conditions such as acne, rosacea, psoriasis, and alopecia, and emphasizes the importance of managing cardiovascular risks in affected patients.
December 2024 in “Quality in Sport” This review found that modifying diet and lifestyle can significantly influence the progression and management of autoimmune diseases by reducing inflammation, supporting immune regulation, and addressing comorbidities, with potential benefits from anti-inflammatory diets, probiotics, and personalized approaches.
January 2023 in “Pediatric Endocrinology Diabetes and Metabolism” This review discusses current knowledge of isolated premature pubarche in infants and reports no new findings, highlighting it as a mild, self-limiting condition that necessitates exclusion of serious causes.
November 2022 in “Journal of Education, Health and Sport” This review discusses various pharmacotherapies for androgenetic alopecia, concluding that combination therapies may offer more effective treatment, though more research on alternative preparations is needed.
September 2021 in “Journal of Education, Health and Sport” This review examines the potential link between androgenetic alopecia and COVID-19, finding insufficient evidence for a cause-and-effect relationship and calling for further research.
April 2026 in “Quality in Sport” This review discusses the cardiovascular risks and events associated with anabolic-androgenic steroid use, suggesting the need for further research on some effects.